Novartis AG

Pharmaceuticals
Switzerland
Earnings Per Share Growth (%)76.51%
Cost of Goods Sold (US$ Millions)$17,404
Current Liabilities (US$ Millions)$23,708
Total Assets (US$ Millions)$22,845
Long Term Debt$16,327
Return on Equity25.13%
Revenue (US$ Millions)$50,387
Total Company Assets$131,556
Revenue Growth (%)-6.05%
Net Income (US$ Millions)$17,783
Earnings Per Share (US$)$76.51
Total Equity (US$ Millions)$77,046
Profit Margin (%)35.29%
Debt To Equity Ratio (%)0.21%
Inventory Turnover$6,226